Remote Jobs at Kura Oncology, Inc.

Kura Oncology, Inc.

51 - 200 employees

Founded 2014

🧬 Biotechnology

💊 Pharmaceuticals

💰 $125M Post-IPO Debt on 2022-11

Biotechnology • Pharmaceuticals

Kura Oncology, Inc. is a biopharmaceutical company specializing in the discovery and development of precision medicines designed to target cancer cells selectively. The company focuses on creating novel therapies aimed at improving patient outcomes in areas with significant unmet medical needs, such as head and neck cancer, lung cancer, and acute leukemias. Kura Oncology conducts clinical trials for its pipeline products, including Ziftomenib and Tipifarnib, to find effective treatments for conditions like Acute Myeloid Leukemia and Head and Neck Squamous Cell Carcinoma. The company is committed to the promise of precision oncology, striving to improve the quality and longevity of life for cancer patients by combining innovative therapies with existing standards of care.